Selecting patients for resection after primary chemotherapy for non-metastatic pancreatic adenocarcinoma von Reni, M., Zanon, S., Balzano, G., Nobile, S., Pircher, C.C., Chiaravalli, M., Passoni, P., Arcidiacono, P.G., Nicoletti, R., Crippa, S., Slim, N., Doglioni, C., Falconi, M., Gianni, L.

Volltext

Farnesoid X Receptor Regulates Bile Acid-Amino Acid Conjugation von Pircher, Parinaz C., Kitto, Jennifer L., Petrowski, Mary L., Tangirala, Rajendra K., Bischoff, Eric D., Schulman, Ira G., Westin, Stefan K.

Volltext

Optimal Choice of Adjuvant Treatment for Renal Cell Carcinoma Following Nephrectomy von Bottiglieri, Achille, Sepe, Pierangela, Stellato, Marco, Pircher, Chiara, Fotia, Giuseppe, Leone, Alberto Giovanni, Guadalupi, Valentina, Claps, Melanie, Giannatempo, Patrizia, Verzoni, Elena, Procopio, Giuseppe

Volltext

A rare case of Epstein‐Barr virus‐associated hepatosplenic smooth muscle tumors after kidney transplantation von Pircher, C., Schneeberger, S., Boesmueller, C., Agaimy, A., Zoller, H., Bale, R., Henninger, B., Mayer, G., Neuwirt, H.

Volltext

Regulation of Complement C3 Expression by the Bile Acid Receptor FXR von Li, Jiali, Pircher, Parinaz C, Schulman, Ira G, Westin, Stefan K

Volltext

Randomized phase 2 trial of nab-paclitaxel plus gemcitabine, ± capecitabine, cisplatin (paxg regimen) in metastatic pancreatic adenocarcinoma von Zanon, S., Pircher, C., Chiaravalle, M., Macchini, M., Peretti, U., Balzano, G., Passoni, P., Nicoletti, R., Arcidiacono, P.G., Pepe, G., Doglioni, C., Romi, S., Gritti, E., Falconi, M., Gianni, L., Reni, M.

Volltext

P-167 Type 2 diabetes as a predictive and prognostic factor in advanced pancreatic cancer: Preliminary results of the Italian, observational PANCAKE study von Nichetti, F., Pretta, A., Franza, A., Andena, P., Puzzoni, M., Grelli, G., Lai, E., Pircher, C., Mariani, S., Bartalini, L., Vivaldi, C., Scartozzi, M., Mariani, L., Di Bartolomeo, M., de Braud, F., Niger, M.

Volltext

PO-49: Genomic determinants and clinical relevance of cancer- associated thrombosis in biliary tract cancers von Provenzano, L., Miliziano, D., Nichetti, F., Sposetti, C., Pircher, C., Bini, M., Franza, A., Massa, G., Niger, M., Di Bartolomeo, M., de Braud, F.

Volltext

PD-17 Multicentric prospective study assessing clinical benefit of targeted treatment for patients with biliary tract cancers von Niger, M., Nichetti, F., Soldà, C., Pressiani, T., Bagalà, C., Masi, G., Pircher, C., De Grandis, M., Barsotti, G., Zanuso, V., Bensi, M., Genovesi, V., Pruneri, G., Ricagno, G., Rimassa, L., Salvatore, L., Vivaldi, C., Bergamo, F., Pietrantonio, F., de Braud, F., Lonardi, S.

Volltext

P-169 Early-onset biliary tract cancer: An overview of clinical presentation, risk factors, molecular profile and outcome in a multicentric Italian cohort von Vivaldi, C., Genovesi, V., Nichetti, F., Zanuso, V., Rimini, M., Antonuzzo, L., Formica, V., Pretta, A., Pecora, I., Salani, F., Gusmaroli, E., Bozzarelli, S., Vasile, E., Pircher, C., Lavacchi, D., Morelli, C., Rota, S., Fornaro, L., Gardini, A. Casadei, Rimassa, L., Masi, G.

Volltext

Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction ade... von Raimondi, A, Lonardi, S, Murgioni, S, Cardellino, G G, Tamberi, S, Strippoli, A, Palermo, F, De Manzoni, G, Bencivenga, M, Bittoni, A, Chiodoni, C, Lorenzini, D, Todoerti, K, Manca, P, Sangaletti, S, Prisciandaro, M, Randon, G, Nichetti, F, Bergamo, F, Brich, S, Belfiore, A, Bertolotti, A, Stetco, D, Guidi, A, Torelli, T, Vingiani, A, Joshi, R P, Khoshdeli, M, Beaubier, N, Stumpe, M C, Nappo, F, Leone, A G, Pircher, C C, Leoncini, G, Sabella, G, Farulla, L Airo', Alessi, A, Morano, F, Martinetti, A, Niger, M, Fassan, M, Di Maio, M, Kaneva, K, Milione, M, Nimeiri, H, Sposito, C, Agnelli, L, Mazzaferro, V, Di Bartolomeo, M, Pietrantonio, F

Volltext

P1.15-02 Plasma microRNAs Modulation in Advanced NSCLC Patients Receiving Single Agent Immune Checkpoint Inhibitors von Proto, C., Chiaruttini, M.V., Prelaj, A., Lo Russo, G., Ferrara, R., Manglaviti, S., De Toma, A., Brambilla, M., Occhipinti, M., Beninato, T., Mazzeo, L., Pircher, C., Dumitrascu, A.D., de Braud, F., Segale, M., Garassino, M.C., Sozzi, G., Porcu, L., Rulli, E., Boeri, M.

Volltext

MA10.07 Phase II Trial of Sunitinib in Patients with Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines - STYLE Trial (NCT03449173) von Proto, C., Galli, G., Manglaviti, S., Lo Russo, G., Ganzinelli, M., Galli, F., Musca, M., Rulli, E., Di Mauro, R., Mella, G., Lucarelli, A., Paggio, A., Valleggi, S., Ballatore, Z., Maso, A. Dal, Perrino, M., Chella, A., Sbrana, A., Prelaj, A., Ferrara, R., Occhipinti, M., Brambilla, M., De Toma, A., Mazzeo, L., Beninato, T., Pircher, C., de Braud, F., Pasello, G., Petrini, I., Berardi, R., Garassino, M., Zucali, P.

Volltext

Randomized phase 2 trial of nab-paclitaxel plus gemcitabine, ± capecitabine, cisplatin (PAXG regimen) in unresectable or borderline resectable pancreatic adenocarcinoma von Reni, M., Zanon, S., Balzano, G., Passoni, P., Costantino, A., Pircher, C., Chiaravalli, M., Nicoletti, R., Arcidiacono, P.G., Pepe, G., Crippa, S., Doglioni, C., Fugazza, C., Ceraulo, D., Falconi, M., Gianni, L.

Volltext

Randomized phase 2 trial of nab-paclitaxel plus gemcitabine, ± capecitabine, cisplatin (PAXG regimen) in metastatic pancreatic adenocarcinoma von Reni, M., Zanon, S., Pircher, C., Chiaravalli, M., Macchini, M., Peretti, U., Mazza, E., Balzano, G., Passoni, P., Nicoletti, R., Arcidiacono, P.G., Pepe, G., Doglioni, C., Romi, S., Ceraulo, D., Falconi, M., Gianni, L.

Volltext

TEMPORARY REMOVAL: PO-49: Genomic determinants and clinical relevance of cancer- associated thrombosis in biliary tract cancers von Provenzano, L, Miliziano, D, Nichetti, F, Sposetti, C, Pircher, C, Bini, M, Franza, A, Massa, G, Niger, M, Di Bartolomeo, M, de Braud, F

Volltext

A randomized phase 2 trial of nab-paclitaxel plus gemcitabine, ± capecitabine, cisplatin (paxg regimen) in unresectable or borderline resectable pancreatic adenocarcinoma: the ghos... von Reni, M., Zanon, S., Balzano, G., Passoni, P., Costantino, A., Pircher, C., Chiaravalli, M., Nicoletti, R., Arcidiacono, P.G., Pepe, G., Crippa, S., Doglioni, C., Fugazza, C., Ceraulo, D., Falconi, M., Gianni, L.

Volltext

Selecting patients for resection after primary chemotherapy for non-metastatic pancreatic adenocarcinoma von Reni, M, Zanon, S, Balzano, G, Nobile, S, Pircher, C C, Chiaravalli, M, Passoni, P, Arcidiacono, P G, Nicoletti, R, Crippa, S, Slim, N, Doglioni, C, Falconi, M, Gianni, L

Volltext

A rare case of Epstein-Barr virus-associated hepatosplenic smooth muscle tumors after kidney transplantation von Pircher, C, Schneeberger, S, Boesmueller, C, Agaimy, A, Zoller, H, Bale, R, Henninger, B, Mayer, G, Neuwirt, H

Volltext

The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis von Fidler, Trevor P., Xue, Chenyi, Yalcinkaya, Mustafa, Hardaway, Brian, Abramowicz, Sandra, Xiao, Tong, Liu, Wenli, Thomas, David G., Hajebrahimi, Mohammad Ali, Pircher, Joachim, Silvestre-Roig, Carlos, Kotini, Andriana G., Luchsinger, Larry L., Wei, Ying, Westerterp, Marit, Snoeck, Hans-Willem, Papapetrou, Eirini P., Schulz, Christian, Massberg, Steffen, Soehnlein, Oliver, Ebert, Benjamin, Levine, Ross L., Reilly, Muredach P., Libby, Peter, Wang, Nan, Tall, Alan R.

Volltext